Risk Assessment after ST-Segment Elevation Myocardial Infarction: Can Biomarkers Improve the Performance of Clinical Variables?

Introduction: Myocardial infarction with ST-segment elevation (STEMI) is the coronary artery disease associated with the highest risk of morbimortality; however, this risk is heterogeneous, usually being evaluated by clinical scores. Risk assessment is a key factor in personalized clinical managemen...

Descripción completa

Detalles Bibliográficos
Autores principales: Garcia-Osuna, Alvaro, Sans-Rosello, Jordi, Ferrero-Gregori, Andreu, Alquezar-Arbe, Aitor, Sionis, Alessandro, Ordóñez-Llanos, Jordi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8910980/
https://www.ncbi.nlm.nih.gov/pubmed/35268358
http://dx.doi.org/10.3390/jcm11051266

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8910980/
https://www.ncbi.nlm.nih.gov/pubmed/35268358
http://dx.doi.org/10.3390/jcm11051266

Ejemplares similares